journal
https://read.qxmd.com/read/38630890/successful-treatment-of-carbapenem-resistant-acinetobacter-baumannii-meningitis-with-sulbactam-durlobactam
#1
JOURNAL ARTICLE
Pranita D Tamma, Shanan Immel, Sara M Karaba, Caitlin L Soto, Rick Conzemius, Emily Gisriel, Tsigereda Tekle, Haley Stambaugh, Emily Johnson, Jeffrey A Tornheim, Patricia J Simner
BACKGROUND: The treatment of carbapenem-resistant Acinetobacter baumannii/calcoaceticus complex (CRAB) presents significant treatment challenges. METHODS: We report the case of a 42-year-old woman with CRAB meningitis who experienced persistently positive cerebrospinal fluid (CSF) cultures for 13 days despite treatment with high-dose ampicillin-sulbactam and cefiderocol. On day 13, she was transitioned to sulbactam-durlobactam and meropenem; four subsequent CSF cultures remained negative...
April 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38630853/forecasting-hepatitis-c-virus-status-for-children-in-the-united-states-a-modeling-study
#2
JOURNAL ARTICLE
Robert B Hood, Alison H Norris, Abigail Shoben, William C Miller, Randall E Harris, Laura W Pomeroy
BACKGROUND: Virtually all cases of hepatitis C virus (HCV) infection in children in the United States occur through vertical transmission, but it is unknown how many children are infected. Cases of maternal HCV infection have increased in the United States, which may increase the number of children vertically infected with HCV. Infection has long-term consequences for a child's health, but treatment options are now available for children ≥3 years old. Reducing HCV infections in adults could decrease HCV infections in children...
April 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38630638/vaccine-preventable-disease-outbreaks-among-healthcare-workers-a-scoping-review
#3
JOURNAL ARTICLE
Tasnim Hasan, Michelle Lynch, Catherine King, Charbel Wehbe, Martin Plymoth, Md Saiful Islam, Theodore Iannuzzi, Aiken Dao, Jana Lai, Alexandra Martiniuk, Shalini Desai, Meru Sheel
BACKGROUND: Outbreaks of vaccine preventable diseases (VPDs) in health care workers (HCWs) can result in morbidity and mortality and cause significant disruptions to health care services, patients and visitors as well as an added burden on the health system. This scoping review is aimed to describe the epidemiology of VPD outbreaks in HCW, caused by diseases which are prevented by the ten vaccines recommended by World Health Organization (WHO) for HCWs. METHODS: In April 2022 CINAHL, MEDLINE, Global Health and EMBASE were searched for all articles reporting on VPD outbreaks in HCWs since the year 2000...
April 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38629511/retrospective-monkeypox-virus-mpxv-surveillance-among-male-users-of-i-want-the-kit-in-maryland-united-states
#4
JOURNAL ARTICLE
Yukari C Manabe, Justin Hardick, Katherine Uhteg, Nisha Ramdeep, Gretchen Armington, Heba H Mostafa, Matthew M Hamill
Retrospective surveillance leveraging male rectal swab sample remnants from I Want The Kit from July 2021 through October 2023, identified one symptomatic and one asymptomatic mpox case at the peak of transmission in 2022. Although sporadic cases continue to be reported in Maryland, additional asymptomatic cases were not identified in this leveraged surveillance.
April 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38626298/retraction-two-cases-of-interleukin-7-deficient-generalized-verrucosis
#5
(no author information available yet)
No abstract text is available yet for this article.
April 16, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38626241/amoxicillin-clavulanate-breakpoints-against-enterobacterales-rationale-for-revision-by-the-clinical-and-laboratory-standards-institute
#6
JOURNAL ARTICLE
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin-clavulanate (AMC) is among the most frequently prescribed antibiotics globally. It has broad antibacterial activity against gram-positive, gram-negative, and anaerobic bacteria, and has been utilized to treat infections caused by a broad range of pathogens. AMC breakpoints against Enterobacterales were initially set in the 1980s but since then increases in antibiotic resistance, advances in pharmacokinetic (PK)/pharmacodynamic (PD) analyses, and publication of additional clinical data prompted a reassessment by the Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing...
April 16, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38626229/waning-interest-in-infectious-disease-among-trainees-is-medicine-pulling-the-goalie
#7
JOURNAL ARTICLE
George Sakoulas
Relatively low salaries in ID compared to other medical specialties in a world where cost of living is skyrocketing are an easy explanation for unmet needs of ID training programs to fill their positions. However, the interest in ID falling short of expectations may reflect that some features of the ID specialty are counter to select pervasive tendencies of modern culture, including i) slow uptake of innovation into daily routines of ID practioners, ii) the emphasis of clinical mastery of ID practioners in an environment of medical corporatization and increased focus on revenue generation, and iii) the fact that ID practice takes societal interests into consideration (eg...
April 16, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38625062/the-role-of-value-based-healthcare-in-enhancing-antimicrobial-stewardship-for-end-of-life-patients
#8
JOURNAL ARTICLE
Marcelo Carneiro, Ruan Fernandes, João Paulo Telles, Marcia Makdisse, Claudia Fernanda de Lacerda Vidal
No abstract text is available yet for this article.
April 16, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38619537/correction-to-discordant-antibody-and-t-cell-responses-to-the-severe-acute-respiratory-syndrome-coronavirus-2-omicron-variant-in-coronavirus-disease-2019-messenger-rna-vaccine-recipients
#9
(no author information available yet)
No abstract text is available yet for this article.
April 15, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38607928/assessing-the-impact-of-the-2020-council-of-state-and-territorial-epidemiologists-case-definition-for-pertussis-on-reported-pertussis-cases
#10
JOURNAL ARTICLE
Amy B Rubis, Matthew Cole, M Lucia Tondella, Lucia C Pawloski, Erin Youngkin, Patricia Firmender, Vanessa Aden, Victor Cruz, Emma Stanislawski, Rachel Wester, Paul R Cieslak, Anna M Acosta, Tami H Skoff
BACKGROUND: In 2020, the Council of State and Territorial Epidemiologists (CSTE) pertussis case definition was modified; the main change was classifying PCR-positive cases as confirmed, regardless of cough duration. Pertussis data reported through Enhanced Pertussis Surveillance (EPS) in seven sites and the National Notifiable Diseases Surveillance System (NNDSS) were used to evaluate the impact of the new case definition. METHODS: We compared the number of EPS cases with cough onset in 2020 to the number that would have been reported based on the prior (2014) CSTE case definition...
April 12, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38606799/antiretrovirals-and-weight-change-weighing-the-evidence
#11
JOURNAL ARTICLE
David Alain Wohl, John R Koethe, Paul E Sax, Grace A McComsey, Daniel R Kuritzkes, Graeme Moyle, Lee Kaplan, Jean van Wyk, Rafael E Campo, Calvin Cohen
Body weight is influenced by an interplay of individual and environmental factors. In people with HIV (PWH), weight is also influenced by disease status with loss accompanying disease progression that is reversed with effective antiretroviral therapy (ART). Weight changes in comparative ART trials differ by regimen, with greater gains observed with the integrase strand transfer inhibitors (INSTIs) dolutegravir and bictegravir, particularly when co-administered with tenofovir alafenamide fumarate (TAF), compared to regimens that include agents such as tenofovir disoproxil fumarate (TDF) that attenuate weight gain...
April 12, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38606797/which-form-of-tenofovir-should-be-used-worldwide-tdf-or-taf
#12
JOURNAL ARTICLE
Andrew Hill
No abstract text is available yet for this article.
April 12, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38606792/weight-anthropometric-and-metabolic-changes-after-discontinuing-antiretroviral-therapy-containing-tenofovir-alafenamide-taf-in-people-with-hiv
#13
JOURNAL ARTICLE
José Damas, Aline Munting, Jacques Fellay, David Haerry, Catia Marzolini, Philip E Tarr, Ana Steffen, Dominique L Braun, Marcel Stoeckle, Enos Bernasconi, Olivier Nawej Tshikung, Christoph A Fux, Katharine E A Darling, Charles Béguelin, Gilles Wandeler, Matthias Cavassini, Bernard Surial
BACKGROUND: Antiretroviral therapy (ART)-related weight gain is of particular concern in people with HIV (PWH). While weight gain was observed among PWH receiving tenofovir alafenamide (TAF), little is known about the potential reversibility after TAF discontinuation. We evaluated weight and metabolic changes 12 months after TAF discontinuation in the Swiss HIV Cohort Study. METHODS: We included participants who received at least six months of TAF-containing ART between January 2016 and March 2023...
April 12, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38602423/increased-pediatric-respiratory-syncytial-virus-case-counts-following-the-emergence-of-severe-acute-respiratory-syndrome-coronavirus-2-can-be-attributed-to-changes-in-testing
#14
JOURNAL ARTICLE
Brittany A Petros, Carly E Milliren, Pardis C Sabeti, Al Ozonoff
BACKGROUND: Respiratory syncytial virus (RSV) circulation dropped markedly early in the COVID-19 pandemic, followed by a resurgence with heightened case counts. The "immunity debt" hypothesis proposes that the RSV-naїve pediatric population increased during the period of low transmission. However, the evidence supporting this hypothesis is limited, and the role of changing testing practices in the perceived surge has not been comprehensively evaluated. METHODS: We conducted a multicenter, retrospective analysis of 342 530 RSV encounters and 980 546 RSV diagnostic tests occurring at 32 US pediatric hospitals in 2013-2023...
April 11, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38598658/covid-19-vaccine-efficacy-in-participants-with-weakened-immune-systems-from-four-randomized-controlled-trials
#15
JOURNAL ARTICLE
Amy Sherman, Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M Ortega-Villa, Amy Tillman, Jennifer Whitaker, Amanda S Woodward Davis, Brett Leav, Ian Hirsch, Jerald Sadoff, Lisa M Dunkle, Peter B Gilbert, Holly E Janes, James G Kublin, Paul A Goepfert, Karen Kotloff, Nadine Rouphael, Ann R Falsey, Hana M El Sahly, Magdalena E Sobieszczyk, Yunda Huang, Kathleen M Neuzil, Lawrence Corey, Beatriz Grinsztejn, Glenda Gray, Martha Nason, Lindsey R Baden, Cynthia L Gay
BACKGROUND: Although the SARS-CoV-2 vaccines are highly efficacious at preventing severe disease in the general population, current data are lacking regarding vaccine efficacy (VE) for individuals with mild immunocompromising conditions. METHODS: A post-hoc, cross-protocol analysis of participant-level data from the blinded phase of four randomized, placebo-controlled, COVID-19 vaccine phase 3 trials (Moderna, AstraZeneca, Janssen, and Novavax) was performed. We defined a "tempered immune system" (TIS) variable via a consensus panel based on medical history and medications to determine VE against symptomatic and severe COVID-19 cases in TIS participants versus non-TIS (NTIS) individuals starting at 14 days after completion of the primary series through the blinded phase for each of the four trials...
April 10, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38593192/effectiveness-and-safety-of-measures-to-prevent-infections-and-other-complications-associated-with-peripheral-intravenous-catheters-a-systematic-review-and-meta-analysis
#16
JOURNAL ARTICLE
Andreea Dobrescu, Alexandru Marian Constantin, Larisa Pinte, Andrea Chapman, Piotr Ratajczak, Irma Klerings, Robert Emprechtinger, Benedetta Allegranzi, Walter Zingg, M Lindsay Grayson, Joao Toledo, Gerald Gartlehner, Barbara Nussbaumer-Streit
BACKGROUND: Peripheral intravenous catheters (PIVCs) contribute substantially to the global burden of infections. This systematic review assessed 24 infection prevention and control (IPC) interventions to prevent PIVC-associated infections and other complications. METHODS: We searched Ovid MEDLINE, Embase, Cochrane Library, WHO Global Index Medicus, CINAHL and reference lists for controlled studies, from January 1, 1980-March 16, 2023. We dually selected studies, assessed risk of bias, extracted data, and rated the certainty of evidence (COE)...
April 9, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38592950/clinical-outcomes-in-children-living-with-hiv-treated-for-non-severe-tuberculosis-in-the-shine-trial
#17
JOURNAL ARTICLE
Chishala Chabala, Eric Wobudeya, Marieke M van der Zalm, Monica Kapasa, Priyanka Raichur, Robert Mboizi, Megan Palmer, Aarti Kinikar, Syed Hissar, Veronica Mulenga, Vidya Mave, Philippa Musoke, Anneke C Hesseling, Helen McIlleron, Diana Gibb, Angela Crook, Anna Turkova
BACKGROUND: Children living with HIV(CLWH) are at high risk of tuberculosis(TB) and face poor outcomes, despite antiretroviral treatment(ART). We evaluated outcomes in CLWH and HIV-uninfected children treated for non-severe TB in the SHINE trial. METHODS: SHINE was a randomized trial that enrolled children aged <16 years with smear-negative, non-severe TB who were randomized to receive 4 vs 6 months of TB treatment and followed for 72 weeks. We assessed TB relapse/recurrence, mortality, hospitalizations, grade ≥3 adverse events by HIV status, and HIV virological suppression in CLWH...
April 9, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38576380/low-risk-staphylococcus-aureus-bacteremia-patients-do-not-require-routine-diagnostic-imaging-a-multicenter-retrospective-cohort-study
#18
JOURNAL ARTICLE
M M C Hendriks, K S A Schweren, A Kleij, M A H Berrevoets, E de Jong, P van Wijngaarden, H S M Ammerlaan, A N Vos, S van Assen, K Slieker, E H Gisolf, M G Netea, J Ten Oever, I J E Kouijzer
BACKGROUND: Risk stratification to categorize patients with Staphylococcus aureus bacteremia (SAB) as low- or high-risk for metastatic infection may direct diagnostic evaluation and enable personalized management. We investigated the frequency of metastatic infections in low-risk SAB patients, their clinical relevance, and whether omission of routine imaging is associated with worse outcomes. METHODS: We performed a retrospective cohort study in seven Dutch hospitals among adult patients with low-risk SAB, defined as hospital-acquired infection without treatment delay, absence of prosthetic material, short duration of bacteremia, and rapid defervescence...
April 5, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38576379/vertical-transmission-of-hepatitis-c-virus-among-women-with-a-history-of-injection-opioid-use
#19
JOURNAL ARTICLE
John M Cafardi, Hong T Lin, Lana Lange, Lacey Kelley, Kelly Lemon, Elizabeth A Odegard, Heidi L Meeds, Jason T Blackard, Judith Feinberg
We evaluated vertical transmission and linkage to care in women with HCV and history of injection drug use employing co-localized testing and treatment. Transmission occurred in 1 of 23 infants, with mother-infant genetic distance of 1.26%. Rates for infant testing, maternal linkage and cure were 77%, 52%, and 100%, respectively.
April 5, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38573320/surge-of-mpox-cases-in-lombardy-region-italy-october-2023-january-2024
#20
JOURNAL ARTICLE
Davide Moschese, Angelo Roberto Raccagni, Andrea Giacomelli, Antonio Piralla, Roberto Rossotti, Alessandro Raimondi, Daniele Tesoro, Luigi Vezzosi, Maurizio Gulletta, Nicola Clementi, Serena Venturelli, Susanna Benardon, Davide Ricaboni, Dario Bernacchia, Alessandro Mancon, Francesca Rovida, Federica Attanasi, Danilo Cereda, Maria Rita Gismondo, Andrea Gori, Giuliano Rizzardini, Spinello Antinori, Fausto Baldanti, Angelo Valerio Marzano, Giulia Marchetti, Francesco Castelli, Antonella Castagna, Silvia Nozza, Davide Mileto
No abstract text is available yet for this article.
April 4, 2024: Clinical Infectious Diseases
journal
journal
20074
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.